Company Profiles

driven by the PitchBook Platform

Silk Therapeutics

Silk Therapeutics
2013 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Series A3 LATEST DEAL TYPE
$11M LATEST DEAL AMOUNT
$22.2M TOTAL AMOUNT RAISED
Description

Manufacturer and seller of skin-care products. The company develops, manufactures and sells silk-based medical and consumer health products using minimal, highly-concentrated ingredients enabling it to bring positive change in the skincare industry and in the lives of consumers.

Formerly Known As
Silk Cosmetics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Personal Products
Primary Office
196 Boston Avenue
Suite 1100
Medford, MA 02155
United States

+1 (866) 809-0367
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Silk Therapeutics’s full profile, request a free trial.

Silk Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC (Series A3) 28-Sep-2017 $11M $22.2M 0000 Completed Generating Revenue
4. Early Stage VC (Series A2) 02-Feb-2016 000 000.00 000.00 Completed Generating Revenue
3. Early Stage VC (Series A1) 06-May-2015 000 00.000 0000 Completed Generating Revenue
2. Early Stage VC (Series A1) 27-Aug-2014 $2M $4.25M $10M Completed Generating Revenue
1. Early Stage VC (Series A) 24-Mar-2014 $1.2M $1.2M $3.58M Completed Generating Revenue
To view this company’s complete deal history including valuation and funding request access »

Silk Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A3 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A2 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A1 4,066,664 $0.000010 $0.06 $0.75 $0.75 1x $0.75 15.27%
Series A 3,535,296 $0.000010 $0.03 $0.34 $0.34 1x $0.34 13.28%
To view this company’s complete Cap Table request access »

Silk Therapeutics Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Altman Health Investments Other Minority 000 0000 000000 0
BML Group Other Minority 000 0000 000000 0
Brandywine Trust Company PE/Buyout Minority 000 0000 000000 0
Erin Donahue Angel (individual) Minority 000 0000 000000 0
Lear Corporation Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »

Silk Therapeutics Executive Team (4)

Name Title Board
Seat
Contact
Info
Gregory Altman Ph.D Co-Founder, Board Member & Chief Executive Officer
Scott Packard Chief Financial Officer
Rebecca Lacouture Ph.D Chief Operating Officer & Co-Founder
David Kaplan Ph.D Chairman, Scientific Advisory Board

Silk Therapeutics Board Members (7)

Name Representing Role Since Contact
Info
Brendan O'Leary Ph.D Self Board Member 000 0000
Daniel Kraft The Kraft Family Foundation Board Member 000 0000
David Kaplan Ph.D Silk Therapeutics Chairman, Scientific Advisory Board 000 0000
Gregory Altman Ph.D Silk Therapeutics Co-Founder, Board Member & Chief Executive Officer 000 0000
Jeffrey Vinik Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »